Establishment of highly metastatic sublines and insights into telomerase expression during tumor metastasis using a microfluidic system
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces a microfluidic system to screen highly metastatic cancer cells, revealing a link between high telomerase activity and metastasis. The system successfully isolated high-metastasis (LoVo-H) and low-metastasis (LoVo-L) colorectal cancer sublines for further research.
Area Of Science
- Oncology
- Biotechnology
- Molecular Biology
Background
- Metastasis is a key characteristic of malignant tumors, often associated with high telomerase expression.
- Understanding the real-time dynamics of telomerase is crucial for insights into tumor metastasis.
Purpose Of The Study
- To develop a microfluidic system for screening highly metastatic cancer sublines based on cell invasiveness.
- To investigate telomerase expression during tumor metastasis.
- To explore genes and signaling pathways involved in tumor metastasis.
Main Methods
- A microfluidic system was designed to classify cells by metastatic ability.
- Telomerase activity was monitored using fluorescence imaging.
- High-metastasis (LoVo-H) and low-metastasis (LoVo-L) sublines were established from LoVo colorectal cancer cells.
- Transcriptome sequencing was performed to identify differentially expressed genes.
Main Results
- The microfluidic system efficiently separated cells with different metastatic potentials.
- Higher metastasis ability correlated with stronger telomerase activity.
- LoVo-H cells exhibited enhanced proliferation and invasiveness compared to LoVo-L cells.
- 6776 differentially expressed genes were identified, with enrichment in pathways like PI3K-Akt signaling and extracellular matrix interactions.
Conclusions
- The developed microfluidic system is effective for selecting highly metastatic sublines.
- The established LoVo-H subline serves as a valuable model for metastasis research.
- This study provides preliminary insights into telomerase expression during metastasis and offers a new strategy for cancer research and diagnosis.

